These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 16203815

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.
    Ferreri AJ, Assanelli A, Crocchiolo R, Ciceri F.
    Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. New treatment approaches in primary central nervous system lymphoma.
    Soussain C, Hoang-Xuan K, Doolittle ND.
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):719-28, vii. PubMed ID: 16083832
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Primary central nervous system lymphoma: an update.
    Soussain C, Hoang-Xuan K.
    Curr Opin Oncol; 2009 Nov; 21(6):550-8. PubMed ID: 19684518
    [Abstract] [Full Text] [Related]

  • 7. Primary CNS lymphoma.
    Hochberg FH, Baehring JM, Hochberg EP.
    Nat Clin Pract Neurol; 2007 Jan; 3(1):24-35. PubMed ID: 17205072
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Active and passive immunotherapy for lymphoma: proving principles and improving results.
    Brody J, Kohrt H, Marabelle A, Levy R.
    J Clin Oncol; 2011 May 10; 29(14):1864-75. PubMed ID: 21482977
    [Abstract] [Full Text] [Related]

  • 11. Case report of a patient with primary central nervous system lymphoma treated with radioimmunotherapy.
    Shah JJ, Meredith R, Shen S, Nabors B, Lobuglio A, Yester M, Forero A.
    Clin Lymphoma Myeloma; 2006 Nov 10; 7(3):236-8. PubMed ID: 17229341
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Use of antibodies or their fragments for the treatment of tumors].
    Douillard JY, Chatal JF.
    Bull Cancer; 1998 Nov 10; 85(11):951-9. PubMed ID: 9951422
    [Abstract] [Full Text] [Related]

  • 14. Primary CNS lymphoma in immunocompetent patients.
    Sierra del Rio M, Rousseau A, Soussain C, Ricard D, Hoang-Xuan K.
    Oncologist; 2009 May 10; 14(5):526-39. PubMed ID: 19433528
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Malignant lymphoma of the central nervous system: difficult histologic diagnosis after glucocorticoid therapy prior to biopsy.
    Choi YL, Suh YL, Kim D, Ko YH, Sung CO, Lee JI.
    Clin Neuropathol; 2006 May 10; 25(1):29-36. PubMed ID: 16465772
    [Abstract] [Full Text] [Related]

  • 19. [Primary central nervous system lymphoma: diagnosis, management and current topics].
    Arita N.
    No To Shinkei; 2004 Mar 10; 56(3):195-203. PubMed ID: 15112444
    [No Abstract] [Full Text] [Related]

  • 20. Pretargeted radioimmunotherapy for B-cell lymphomas.
    Green DJ, Pagel JM, Pantelias A, Hedin N, Lin Y, Wilbur DS, Gopal A, Hamlin DK, Press OW.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 2):5598s-5603s. PubMed ID: 17875795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.